Sabina A. Guler

2.2k total citations · 1 hit paper
62 papers, 1.3k citations indexed

About

Sabina A. Guler is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Sabina A. Guler has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Sabina A. Guler's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (44 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Sabina A. Guler is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (44 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Sabina A. Guler collaborates with scholars based in Switzerland, Canada and United States. Sabina A. Guler's co-authors include Christopher J. Ryerson, Alyson W. Wong, Thomas Geiser, Manuela Funke-Chambour, Kerri A. Johannson, G.C. Goobie, Jolene H. Fisher, Pearce Wilcox, Christian F. Clarenbach and Martin Brutsche and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Sabina A. Guler

52 papers receiving 1.3k citations

Hit Papers

Pulmonary function and ra... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabina A. Guler Switzerland 18 838 266 249 164 154 62 1.3k
Nurhan Seyahi Türkiye 17 548 0.7× 79 0.3× 116 0.5× 40 0.2× 82 0.5× 107 1.3k
RB Hubbard United Kingdom 15 404 0.5× 159 0.6× 36 0.1× 60 0.4× 58 0.4× 34 1.0k
Irappa Madabhavi India 13 406 0.5× 72 0.3× 41 0.2× 51 0.3× 89 0.6× 73 786
Ahmed Elgebaly Egypt 16 94 0.1× 96 0.4× 132 0.5× 105 0.6× 64 0.4× 49 871
Esteban López de Sá Spain 28 196 0.2× 62 0.2× 140 0.6× 103 0.6× 118 0.8× 181 2.7k
Leticia León Spain 20 139 0.2× 82 0.3× 88 0.4× 124 0.8× 126 0.8× 75 1.0k
Soheir Adam United States 17 125 0.1× 80 0.3× 47 0.2× 36 0.2× 76 0.5× 56 1.4k
Gilbert B. Zulian Switzerland 20 249 0.3× 152 0.6× 63 0.3× 162 1.0× 28 0.2× 64 1.2k
Marten R. Nijziel Netherlands 24 176 0.2× 97 0.4× 32 0.1× 162 1.0× 62 0.4× 53 1.4k
Ella Huszti Canada 17 277 0.3× 64 0.2× 37 0.1× 37 0.2× 10 0.1× 117 1.7k

Countries citing papers authored by Sabina A. Guler

Since Specialization
Citations

This map shows the geographic impact of Sabina A. Guler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabina A. Guler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabina A. Guler more than expected).

Fields of papers citing papers by Sabina A. Guler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabina A. Guler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabina A. Guler. The network helps show where Sabina A. Guler may publish in the future.

Co-authorship network of co-authors of Sabina A. Guler

This figure shows the co-authorship network connecting the top 25 collaborators of Sabina A. Guler. A scholar is included among the top collaborators of Sabina A. Guler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabina A. Guler. Sabina A. Guler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khor, Yet H., Andreas Palm, Alyson W. Wong, et al.. (2025). Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study. Thorax. 80(6). 378–384.
2.
Frei, Anja, Anne E. Holland, Kathleen O. Lindell, et al.. (2025). Specific content for education and self-management programmes for people with pulmonary fibrosis: a co-creation, multiphase, mixed-method study. ERJ Open Research. 11(6). 245–2025.
3.
Lichtblau, Mona, Laura Mayer, Thomas Frauenfelder, et al.. (2025). Impact of the establishment of a multidisciplinary national chronic thromboembolic pulmonary hypertension board on a monocentric surgical endarterectomy program. Interdisciplinary CardioVascular and Thoracic Surgery. 40(3).
4.
Guler, Sabina A., et al.. (2024). Effect of type of delivery and anesthesia method to ABR results on newborn hearing screening. International Journal of Pediatric Otorhinolaryngology. 188. 112185–112185. 1 indexed citations
5.
Guler, Sabina A., et al.. (2024). Interdisciplinary Diagnosis and Management of Patients With Interstitial Lung Disease and Connective Tissue Disease. CHEST Journal. 166(2). 352–361. 2 indexed citations
6.
Leichtle, Alexander, Sabina Berezowska, Sabina A. Guler, et al.. (2023). Signs of Alveolar Collapse in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis and Systemic Sclerosis Revealed by Inspiration and Expiration Computed Tomography. SHILAP Revista de lepidopterología. 3(4). 471–483. 2 indexed citations
7.
Daccord, Cécile, Eric Bernasconi, Martin Brutsche, et al.. (2023). Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis. ERJ Open Research. 9(3). 720–2022. 3 indexed citations
8.
Lenoir, Alexandra, Andreas Christe, Lukas Ebner, et al.. (2022). Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study. Respiration. 102(2). 120–133. 16 indexed citations
9.
Guler, Sabina A., Carlos Machahua, Thomas Geiser, et al.. (2022). Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study. Respiratory Research. 23(1). 149–149. 11 indexed citations
10.
Guler, Sabina A., Kathleen O. Lindell, Jeff Swigris, & Christopher J. Ryerson. (2021). What Is Idiopathic Pulmonary Fibrosis? IPF Part 1. American Journal of Respiratory and Critical Care Medicine. 203(2). P5–P6. 6 indexed citations
11.
Guler, Sabina A., Kathleen O. Lindell, Jeff Swigris, & Christopher J. Ryerson. (2021). Nondrug Treatments for Idiopathic Pulmonary Fibrosis: IPF Part 3. American Journal of Respiratory and Critical Care Medicine. 203(4). P10–P11.
12.
Machahua, Carlos, Sabina A. Guler, Michael P. Horn, et al.. (2021). Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts. BMJ Open Respiratory Research. 8(1). e000827–e000827. 22 indexed citations
13.
Guler, Sabina A., et al.. (2021). Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study. Respiratory Research. 22(1). 120–120. 5 indexed citations
14.
Guler, Sabina A., et al.. (2021). Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional Analysis. JMIR Public Health and Surveillance. 7(5). e24199–e24199. 8 indexed citations
15.
Guler, Sabina A., Lukas Ebner, Pierre‐Olivier Bridevaux, et al.. (2021). Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. European Respiratory Journal. 57(4). 2003690–2003690. 265 indexed citations breakdown →
16.
Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2020). Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease. Annals of the American Thoracic Society. 17(9). 1077–1084. 5 indexed citations
17.
Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2019). Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. CHEST Journal. 156(5). 887–895. 15 indexed citations
18.
Guler, Sabina A., et al.. (2019). Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease. Lung. 197(4). 415–425. 12 indexed citations
19.
Guler, Sabina A., et al.. (2015). Cochlear involvement in patients with ulcerative colitis. The Journal of Laryngology & Otology. 130(2). 128–133. 6 indexed citations
20.
Çakır, B., Ersin Odabaşı, Mustafa Turan, Sabina A. Guler, & Mustafa Kutlu. (2002). Secondary osteoporosis in women. Archives of Gynecology and Obstetrics. 266(4). 214–217. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026